In depth analysis of genes differentially expressed between breast tumour samples from patients with IBC and other breast tumour samples revealed a potential hyperactivation of NF-κB in IBC (Van Laere et al, 2005), which was validated and confirmed in an independent study (Van Laere et al, 2006b). Here, NFKB1 is linked to inflammatory breast carcinoma.